Mong‐Lien Wang
- Cancer Research top 1%
- MicroRNA in disease regulation 15
- Cancer-related molecular mechanisms research 15
- Molecular Biology top 5%
- CRISPR and Genetic Engineering 11
- RNA modifications and cancer 11
- Circular RNAs in diseases 10
- Oncology top 5%
- Cancer Cells and Metastasis 11
- Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research 14
- COVID-19 Clinical Research Studies 11
- Genetics top 5%
Mong‐Lien Wang
95 papers receiving 4.1k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Cancer Research 1.1k
- Molecular Biology 2.4k
- Oncology 923
- Infectious Diseases 603
- Genetics 211
Countries citing papers authored by Mong‐Lien Wang
This map shows the geographic impact of Mong‐Lien Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mong‐Lien Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mong‐Lien Wang more than expected).
Fields of papers citing papers by Mong‐Lien Wang
This network shows the impact of papers produced by Mong‐Lien Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mong‐Lien Wang. The network helps show where Mong‐Lien Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mong‐Lien Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 9 | |
| 4 | 2022 | 7 | |
| 5 | 2022 | 16 | |
| 6 | 2021 | 100 | |
| 7 | 2021 | 24 | |
| 8 | 2021 | 34 | |
| 9 | 2021 | 5 | |
| 10 | 2020 | 55 | |
| 11 | 2020 | 33 | |
| 12 | 2020 | 18 | |
| 13 | 2020 | 13 | |
| 14 | 2016 | 13 | |
| 15 | 2015 | 115 | |
| 16 | 2013 | 115 | |
| 17 | 2012 | 50 | |
| 18 | 2012 | 41 | |
| 19 | 2010 | 496 | |
| 20 | 2003 | 61 |
About Mong‐Lien Wang
Mong‐Lien Wang is a scholar working on Cancer Research, Infectious Diseases, Molecular Biology, Oncology and Ophthalmology, having authored 96 papers that have together received 4.1k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (15 papers), Cancer-related molecular mechanisms research (15 papers), SARS-CoV-2 and COVID-19 Research (14 papers), COVID-19 Clinical Research Studies (11 papers), Cancer Cells and Metastasis (11 papers), CRISPR and Genetic Engineering (11 papers), RNA modifications and cancer (11 papers) and Circular RNAs in diseases (10 papers). The work is most often cited by research in Cancer Research (1.1k citations), Molecular Biology (2.4k citations), Oncology (923 citations), Infectious Diseases (603 citations) and Genetics (211 citations). Mong‐Lien Wang has collaborated with scholars based in Taiwan, Malaysia and United States. Frequent co-authors include Shih‐Hwa Chiou, Chian‐Shiu Chien, Aliaksandr A. Yarmishyn, Shih-Hwa Chiou, Yueh Chien, Yi‐Ping Yang, Shih‐Jie Chou, Yung‐Hung Luo, Shih-Hwa Chiou and Pin‐I Huang. Their work appears in journals such as International Journal of Molecular Sciences, Cancers, Oncotarget, Cancer Research and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.